Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study: Randomised clinical trial: the ASBT/IBAT inhibitor A3309 in constipation

Chronic constipation: a survey of the patient perspective

JOHANSON, J. F., & KRALSTEIN, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03238.x · Cited by 617 · see citing works

Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate.

O'Donnell, L. J. D., Virjee, J., & Heaton, K. (1990) · British medical journal · doi:10.1136/bmj.300.6722.439 · Cited by 537 · see citing works

An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking

Paré, P., Ferrazzi, S., Thompson, W., Irvine, E. J., & Rance, L. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05259.x · Cited by 445 · see citing works

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

Lundåsen, T., Gälman, C., Angelin, B., & Rudling, M. J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01731.x · Cited by 406 · see citing works

Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation

Johanson, J. F., Morton, D., Geenen, J., & Ueno, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01524.x · Cited by 331 · see citing works

Long-term results of surgery for chronic constipation

Nyam, D., Pemberton, J., Ilstrup, D., & Rath, D. M. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02050415 · Cited by 255 · see citing works

Efficacy of Linaclotide for Patients With Chronic Constipation

Lembo, A. J., Kurtz, C. B., MacDougall, J. E., Lavins, B. J., Currie, M. G., Fitch, D. A., Jeglinski, B. I., & Johnston, J. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.050 · Cited by 234 · see citing works

Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood

Gälman, C., Arvidsson, I., Angelin, B., & Rudling, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.d200043-jlr200 · Cited by 194 · see citing works

Gender Differences in Gut Transit Shown with a Newly Developed Radiological Procedure

Sadik, R., Abrahamsson, H., & Stotzer, P.-O. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000410 · Cited by 183 · cited 1× · see citing works

Bile acids: short and long term effects in the intestine

Bajor, A., Gillberg, P., & Abrahamsson, H. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003702734 · Cited by 138 · see citing works

Chronic constipation: overview and challenges

Cook, I. J., Talley, N. J., Benninga, M. A., Rao, S. S. C., & Scott, S. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01399.x · Cited by 104 · see citing works

Accelerated Regional Bowel Transit and Overweight Shown in Idiopathic Bile Acid Malabsorption

Sadik, R., Abrahamsson, H., Ung, K., & Stotzer, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04139.x · Cited by 103 · see citing works

Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre

Sadik, R., Stotzer, P. ‐., Simrén, M., & Abrahamsson, H. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01025.x · Cited by 81 · see citing works

Pharmacological management of constipation

Emmanuel, A. V., Tack, J. F., Quigley, E. M. M., & Talley, N. J. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01403.x · Cited by 75 · see citing works

Bile acid malabsorption

Westergaard, H. (2007) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-007-0054-7 · Cited by 72 · see citing works

Taking a Lesson From Microbial Diarrheagenesis in the Management of Chronic Constipation

Bharucha, A. E., & Waldman, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.022 · Cited by 45 · see citing works

Accuracy in assessment of colonic transit time with particles: how many markers should be used?

Abrahamsson, H., & Antov, S. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01543.x · Cited by 29 · see citing works

Colonoscopy and SeHCAT for Investigation of Chronic Diarrhea

Müller, M. C. A., Wïllén, R., & Stotzer, P. (2004) · Digestion · doi:10.1159/000079150 · Cited by 28 · see citing works

S1301 The IBAT Inhibition by A3309 – A Potential Mechanism for the Treatment of Constipation

Gillberg, P., Dahlström, M., Starke, I., & Östlund‐Lindqvist, A. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)61017-7 · Cited by 25 · see citing works

286 Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

Lembo, A. J., Schneier, H. A., Lavins, B. J., Shiff, S. J., MacDougall, J. E., Jia, X. D., Kurtz, C. B., Currie, M. G., & Johnston, J. M. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)60244-2 · Cited by 20 · see citing works

Bowel Disorders

Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866 · see citing works

American Gastroenterological Association Technical Review on Constipation

Bharucha, A. E., Pembérton, J. H., & Locke, G. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.028 · Cited by 914 · see citing works

American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 648 · see citing works

Management of functional constipation in children and adults

Vriesman, M. H., Koppen, I. J. N., Camilleri, M., Di Lorenzo, C., & Benninga, M. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0222-y · Cited by 457 · see citing works

Bile acid transporters and regulatory nuclear receptors in the liver and beyond

Halilbasic, E., Claudel, T., & Trauner, M. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.002 · Cited by 397 · see citing works

Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades

Hofmann, A. F., & Hagey, L. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r049437 · Cited by 359 · see citing works

Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease

Hegyi, P., Maléth, J., Walters, J. R., Hofmann, A. F., & Keely, S. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00054.2017 · Cited by 269 · see citing works

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea‐predominant irritable bowel syndrome

Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01893.x · Cited by 256 · see citing works

Intestinal absorption of bile acids in health and disease

Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190007 · Cited by 215 · see citing works

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS

Bajor, A., Törnblom, H., Rudling, M., Ung, K., & Simrén, M. (2014) · Gut · doi:10.1136/gutjnl-2013-305965 · Cited by 207 · see citing works

Constipation: Pathophysiology and Current Therapeutic Approaches

Sharma, A., & Rao, S. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_111 · Cited by 190 · see citing works

Role of gut microbiota in functional constipation

Zhang, S., Wang, R., Li, D., Zhao, L., & Zhu, L. (2021) · Gastroenterology Report · doi:10.1093/gastro/goab035 · Cited by 175 · see citing works

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial

Nakajima, A., Seki, M., Taniguchi, S., Ohta, A., Gillberg, P.-G., Mattsson, J. P., & Camilleri, M. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30123-7 · Cited by 169 · see citing works

Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters

Anwer, M. S., & Stieger, B. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1367-0 · Cited by 150 · see citing works

New treatments and therapeutic targets for IBS and other functional bowel disorders

Simrén, M., & Tack, J. (2018) · Nature reviews: Gastroenterology & hepatology · doi:10.1038/s41575-018-0034-5 · Cited by 127 · see citing works

Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation

Wong, B. S., Camilleri, M., McKinzie, S., Burton, D., Graffner, H., & Zinsmeister, A. R. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.285 · Cited by 133 · see citing works

The SLC10 Carrier Family

Döring, B., Lütteke, T., Geyer, J., & Petzinger, E. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394316-3.00004-1 · Cited by 128 · see citing works

Effects of Ficus carica paste on loperamide-induced constipation in rats

Lee, H.-Y., Kim, J., Jeung, H.-W., Lee, C.-U., Kim, D., Li, B., Lee, G., Sung, M.-S., Ha, K.-C., Back, H., et al. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.12.001 · Cited by 104 · see citing works

Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria

Ford, A. C., Bercik, P., Morgan, D. G., Bolino, C., Pintos‐Sanchez, M. I., & Moayyedi, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12573 · Cited by 102 · see citing works

Solute carriers as drug targets: Current use, clinical trials and prospective

Rask‐Andersen, M., Masuram, S., Fredriksson, R., & Schiöth, H. B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.015 · Cited by 98 · see citing works

Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition

Shin, J. E., Jung, H., Lee, T. H., Jo, Y., Lee, H., Song, K. H., Hong, S. N., Lim, H. C., Lee, S. J., Chung, S. S., et al. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15185 · Cited by 96 · see citing works

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH

Al-Dury, S., & Marschall, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00931 · Cited by 96 · see citing works

The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation

Graffner, H., Gillberg, P., Rikner, L., & Marschall, H. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13457 · Cited by 94 · see citing works

Elobixibat and its potential role in chronic idiopathic constipation

Acosta, A., & Camilleri, M. (2014) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x14528269 · Cited by 91 · see citing works

Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis

Kamath, B. M., Stein, P., Houwen, R. H. J., & Verkade, H. J. (2020) · Liver International · doi:10.1111/liv.14553 · Cited by 88 · see citing works

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis

Al-Dury, S., Wahlstrom, A. M., Wåhlin, S., Langedijk, J., Elferink, R. P. J. O., Ståhlman, M., & Marschall, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-25214-0 · Cited by 85 · see citing works

Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples

Vijayvargiya, P., Busciglio, I. A., Burton, D. D., Donato, L. J., Lueke, A. J., & Camilleri, M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.039 · Cited by 84 · see citing works

Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study

Newsome, P. N., Palmer, M., Freilich, B., Sheikh, M. Y., Sheikh, A., Sarles, H., Herring, R., Mantry, P., Kayali, Z., Hassanein, T., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.024 · Cited by 80 · see citing works

An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT)

Xiao, L., & Pan, G. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.02.001 · Cited by 77 · see citing works

Brain‐Gut Axis

Camilleri, M., & Lorenzo, C. D. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31823d34c3 · Cited by 74 · see citing works

Gastrointestinal dysmotility disorders in critically ill dogs and cats

Whitehead, K., Cortes, Y., & Eirmann, L. (2016) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12449 · Cited by 63 · see citing works

Chronic Constipation: a Review of Current Literature

Sbahi, H., & Cash, B. D. (2015) · Current Gastroenterology Reports · doi:10.1007/s11894-015-0471-z · Cited by 62 · see citing works

Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial

Nakajima, A., Seki, M., & Taniguchi, S. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1383-5 · Cited by 62 · see citing works

Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges

Li, M., Wang, Q., Li, Y., Cao, S., Zhang, Y., Wang, Z., Liu, G., Li, J., & Gu, B. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107539 · Cited by 60 · see citing works

Specific inhibition of bile acid transport alters plasma lipids and GLP-1

Rudling, M. J., Camilleri, M., Graffner, H., Holst, J. J., & Rikner, L. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0070-9 · Cited by 60 · see citing works

An Update of Pharmacological Management in Children with Functional Constipation

de Geus, A., Koppen, I. J. N., Flint, R. B., Benninga, M. A., & Tabbers, M. M. (2023) · Pediatric Drugs · doi:10.1007/s40272-023-00563-0 · Cited by 70 · see citing works

Intestinal Absorption of Bile Acids in Health and Disease

Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2020) · Comprehensive physiology · doi:10.1002/j.2040-4603.2020.tb00108.x · Cited by 60 · see citing works

New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond

Sinagra, E., Morreale, G., Mohammadian, G., Fusco, G., Guarnotta, V., Tomasello, G., Cappello, F., Rossi, F., Amvrosiadis, G., & Raimondo, D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6593 · Cited by 52 · see citing works

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Tiessen, R. G., Kennedy, C., Keller, B. T., Levin, N., Acevedo, L. M., Gedulin, B. R., van Vliet, A. A., Dorenbaum, A., & Palmer, M. (2018) · BMC Gastroenterology · doi:10.1186/s12876-017-0736-0 · Cited by 50 · see citing works

Elobixibat for the treatment of constipation

Chedid, V. G., Vijayvargiya, P., & Camilleri, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1522248 · Cited by 48 · see citing works

Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome

Camilleri, M. (2012) · Clinical pharmacology and therapy · doi:10.1038/clpt.2011.261 · Cited by 43 · see citing works

Evidence-Based Clinical Guidelines for Chronic Constipation 2023

Ihara, E., Manabe, N., Ohkubo, H., Ogasawara, N., Ogino, H., Kakimoto, K., Kanazawa, M., Kawahara, H., Kusano, C., Kuribayashi, S., et al. (2024) · Digestion · doi:10.1159/000540912 · Cited by 53 · see citing works

Understanding and treating refractory constipation

Bassotti, G., & Blandizzi, C. (2014) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v5.i2.77 · Cited by 45 · see citing works

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles

Zhang, B., Kuipers, F., de Boer, J. F., & Kuivenhoven, J. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010004 · Cited by 42 · see citing works

Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment

Spiller, R. E. (2016) · F1000Research · doi:10.12688/f1000research.7992.1 · Cited by 42 · see citing works

Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment

Corsetti, M., Brown, S. R., Chiarioni, G., Dimidi, E., Dudding, T. C., Emmanuel, A. V., Fox, M. R., Ford, A. C., Giordano, P., Grossi, U., et al. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14070 · Cited by 41 · see citing works

Elobixibat for the treatment of constipation

Wong, B. S., & Camilleri, M. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.753056 · Cited by 38 · see citing works

Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.

Jadallah, K. A., Kullab, S. M., & Sanders, D. S. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8898 · Cited by 37 · see citing works

Chronic constipation: new diagnostic and treatment approaches

Lacy, B. E., Levenick, J. M., & Crowell, M. D. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12443093 · Cited by 37 · see citing works

Evolution of substrate specificity for the bile salt transporter ASBT (SLC10A2)

Lionarons, D. A., Boyer, J. L., & Cai, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m025726 · Cited by 35 · see citing works

Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial

Kumagai, Y., Amano, H., Sasaki, Y., Nakagawa, C., Maeda, M., Oikawa, I., & Furuie, H. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13698 · Cited by 35 · see citing works

Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels

Keely, S. J., Urso, A., Ilyaskin, A. V., Korbmacher, C., Bunnett, N. W., Poole, D. P., & Carbone, S. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00125.2021 · Cited by 35 · see citing works

The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer’s Disease

Ehtezazi, T., Rahman, K., Davies, R., & Leach, A. G. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220071 · Cited by 35 · see citing works

Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition

Shin, J. E., Jung, H., Lee, T. H., Jo, Y., Lee, H., Song, K. H., Hong, S. N., Lim, H. C., Lee, S. J., Chung, S. S., et al. (2016) · Korean Journal of Medicine · doi:10.3904/kjm.2016.91.2.114 · Cited by 34 · see citing works

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice

Matsui, M., Fukunishi, S., Nakano, T., Ueno, T., Higuchi, K., & Asai, A. (2021) · mBio · doi:10.1128/mbio.01155-21 · Cited by 33 · see citing works

Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

Hegade, V. S., Jones, D. E., & Hirschfield, G. M. (2017) · Digestive Diseases · doi:10.1159/000450988 · Cited by 32 · see citing works

Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments

Müller-Lissner, S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.773972 · Cited by 31 · see citing works

The Mexican consensus on chronic constipation

Remes-Troche, J. M., Coss‐Adame, E., López‐Colombo, A., Amieva‐Balmori, M., Sánchez, R. C., Guindic, L. C., Rendón, R. F., Escudero, O. G., Martínez, M. G., Chávez, M. E. I., et al. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.05.012 · Cited by 31 · see citing works

Efficacy and safety of prucalopride in adults and children with chronic constipation

Diederen, K., Mugie, S. M., & Benninga, M. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.996547 · Cited by 29 · see citing works

Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials

Valentin, N., Acosta, A. J., & Camilleri, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1025132 · Cited by 29 · see citing works

Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation

Eswaran, S. L., Guentner, A. S., & Chey, W. D. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2014.20.2.141 · Cited by 29 · see citing works

Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation

Nakajima, A., Ishizaki, S., Matsuda, K. M., Kurosu, S., Taniguchi, S., Gillberg, P., Mattsson, J. P., Hasunuma, T., & Camilleri, M. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15800 · Cited by 28 · see citing works

Bile acids and FXR in functional gastrointestinal disorders

Mosińska, P., Szczepaniak, A., & Fichna, J. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.05.016 · Cited by 27 · see citing works

Review article: Elobixibat: a novel treatment for chronic constipation

Khanna, L., & Camilleri, M. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16143 · Cited by 24 · see citing works

Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation

Miner, P. B. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1508450 · Cited by 23 · see citing works

Phase II drugs under clinical investigation for the treatment of chronic constipation

Mozaffari, S., Didari, T., Nikfar, S., & Abdollahi, M. R. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.932770 · Cited by 20 · see citing works

Novel diagnostics and therapy of colonic motor disorders

Dinning, P. G., & Scott, S. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.002 · Cited by 18 · see citing works

Evidence connecting old, new and neglected glucose‐lowering drugs to bile acid‐induced GLP ‐1 secretion: A review

Kårhus, M. L., Brønden, A., Sonne, D. P., Vilsbøll, T., & Knop, F. K. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12946 · Cited by 19 · see citing works

Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review

Mosińska, P., Sałaga, M., & Fichna, J. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1142532 · Cited by 17 · see citing works

Non-systemic Intestine-Targeted Drugs

Fyfe, M. C. T. (2016) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2015.10.001 · Cited by 17 · see citing works

Advancing treatment options for chronic idiopathic constipation

Quigley, E. M. M., & Neshatian, L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1127356 · Cited by 15 · see citing works

Consenso mexicano sobre estreñimiento crónico

Remes-Troche, J. M., Coss‐Adame, E., López‐Colombo, A., Amieva‐Balmori, M., Sánchez, R. C., Guindic, L. C., Rendón, R. F., Escudero, O. G., Martínez, M. G., Chávez, M. E. I., et al. (2018) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2017.12.005 · Cited by 18 · see citing works

Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study

Kamei, D., Kamei, Y., Nagano, M., Mineshima, M., Nitta, K., & Tsuchiya, K. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-1179-6 · Cited by 16 · see citing works

New Options in Constipation Management

Davis, M. P., & Gamier, P. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0481-x · Cited by 16 · see citing works

New pharmacological treatment options for chronic constipation

Corsetti, M., & Tack, J. F. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.900543 · Cited by 15 · see citing works

Absorption, Distribution, Metabolism, and Excretion of [14C]-Volixibat in Healthy Men: Phase 1 Open-Label Study

Siebers, N., Palmer, M., Silberg, D. G., Jennings, L., Bliss, C. A., & Martin, P. T. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0429-7 · Cited by 15 · see citing works

Treatment for constipation: New and old pharmacological strategies

Lacy, B. E., Hussain, Z. H., & Mearin, F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12335 · Cited by 14 · see citing works

Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.

Hussain, Z. H., Everhart, K. K., & Lacy, B. E. (2015) · PubMed Central · Cited by 14 · see citing works

Pharmacotherapeutic advances for chronic idiopathic constipation in adults

Bassotti, G., Usai–Satta, P., Berti, G., Lai, M., Villanacci, V., & Bellini, M. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2150076 · Cited by 13 · see citing works

Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation

Rothstein, R. D., & Friedenberg, F. K. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.833605 · Cited by 13 · see citing works

Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation

Mosińska, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i24.7436 · Cited by 12 · see citing works

New pharmacological treatment options for irritable bowel syndrome with constipation

Nusrat, S., & Miner, P. B. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1105215 · Cited by 11 · see citing works

The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study

Tomie, A., Yoshida, N., Kugai, M., Hirose, R., Dohi, O., Inoue, K., Okuda, K., Motoyoshi, T., Fukumoto, K., Inagaki, Y., et al. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/9656040 · Cited by 11 · see citing works

Drug discovery approaches to irritable bowel syndrome

Hornby, P. J. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1049528 · Cited by 11 · see citing works

A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides

Liu, H., Pang, G., Ren, J., Zhao, Y., & Wang, J. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.11.005 · Cited by 11 · see citing works

Emerging treatments for chronic constipation

Gudsoorkar, V. S., & Quigley, E. M. M. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.831068 · Cited by 10 · see citing works

Gastrointestinal motility and neurogastroenterology

Törnblom, H., Simrén, M., & Abrahamsson, H. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1027265 · Cited by 10 · see citing works

The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs

Савельева, Е. Е., Tyutrina, E. S., Nakanishi, T., Tamai, I., & Salmina, A. B. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206603185 · Cited by 9 · see citing works

Motility disorders of the colon and rectum

Wald, A. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834d4f61 · Cited by 3 · see citing works

Efficacy of elobixibat as bowel preparation agent for colonoscopy: Prospective, randomized, multi‐center study

Yamaguchi, D., Hidaka, H., Matsunaga, T., Akutagawa, T., Tanaka, Y., Jubashi, A., Takeuchi, Y., Tsuruoka, N., Sakata, Y., Miyahara, K., et al. (2021) · Digestive Endoscopy · doi:10.1111/den.14010 · Cited by 8 · see citing works

Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study

Hishida, Y., Nagai, Y., Tsukiyama, H., Nakamura, Y., Nakagawa, T., Ishizaki, S., Tanaka, Y., & Sone, M. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02243-w · Cited by 9 · see citing works

Effects of Elobixibat, an Inhibitor of Ileal Bile Acid Transporter, on Glucose and Lipid Metabolism: A Single-arm Pilot Study in Patients with T2DM

Yoshinobu, S., Hasuzawa, N., Nagayama, A., Iwata, S., Yasuda, J., Tokubuchi, R., Kabashima, M., Gobaru, M., Hara, K., Murotani, K., et al. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.08.009 · Cited by 6 · see citing works

Targeting bile acids in the treatment of constipation

Maneerattanaporn, M., & Chey, W. D. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.63 · Cited by 6 · see citing works

Exploring bile acid transporters as key players in cancer development and treatment: Evidence from preclinical and clinical studies

Bintee, B., Banerjee, R., Hegde, M., Vishwa, R., Alqahtani, M. S., Abbas, M. A. E., Alqahtani, A., Rangan, L., Sethi, G., & Kunnumakkara, A. B. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217324 · Cited by 5 · see citing works

Motility disorders of the colon and rectum

Gras-Miralles, B., Magge, S., Bloom, A., & Lembo, A. J. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a80e7 · Cited by 5 · see citing works

Apple juice relieves loperamide-induced constipation in rats by downregulating the intestinal apical sodium-dependent bile acid transporter ASBT

Zhu, Q., Iwai, R., Okaguchi, T., Shirasaka, Y., & Tamai, I. (2023) · Food & Function · doi:10.1039/d3fo00510k · Cited by 5 · see citing works

Recent Advances in the Management of Difficult Constipation

Lacy, B. E., Levenick, J. M., & Crowell, M. D. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0269-1 · Cited by 4 · see citing works

The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study

Li, B., Hu, Y., Wang, G., & Liu, L. (2020) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-020-00422-5 · Cited by 4 · see citing works

Constipación crónica. Conceptos actuales desde la fisiopatología hasta el tratamiento

García‐Zermeño, K. R. (2021) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/zrrj9030 · Cited by 3 · see citing works

Inhibitors of the Apical Sodium-Dependent Bile Acid Transporter (ASBT) as Promising Drugs

Савельева, Е. Е., Tyutrina, E. S., Nakanishi, T., Tamai, I., & Salmina, A. B. (2021) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750821010078 · Cited by 2 · see citing works

A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation

Chey, W. D., Camilleri, M., Chang, L., Rikner, L., & Graffner, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.162 · Cited by 176 · see citing works

nature publishing group ORIGINAL CONTRIBUTIONS 1803 see related editorial on page x A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor,

Constipation, F. C. I., & Graffner, H. (2013)

Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation

Wong, B. S., Camilleri, M., McKinzie, S., Burton, D., Graffner, H., & Zinsmeister, A. R. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.285 · Cited by 133 · see citing works

Den Teufel durch Beelzebub austreiben?

Müller-Lissner, S. A. (2012) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0032-1312906

Turning Classical Bile Acid Physiology Into Everyday Pharmacology: Impact of a Bile Acid Transporter Inhibitor on Chronic Constipation

Quigley, E. M. M. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.026